EntryPoint Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,208
Closed -$371K 855
2026
Q1
$371K Buy
+5,208
New +$411K 0.11% 377
2025
Q3
Sell
-7,118
Closed -$527K 756
2025
Q2
$527K Sell
7,118
-209
-3% -$14.5K 0.26% 77
2025
Q1
$591K Buy
7,327
+2,766
+61% +$238K 0.27% 55
2024
Q4
$357K Buy
+4,561
New +$388K 0.15% 264
2024
Q3
Sell
-784
Closed -$61.1K 887
2024
Q2
$61.1K Buy
784
+316
+68% +$25.8K 0.03% 1014
2024
Q1
$42.5K Buy
468
+408
+680% +$33.9K 0.04% 839
2023
Q4
$4.64K Buy
+60
New +$4.2K ﹤0.01% 1225

Other funds holding GEHC

EntryPoint Capital's GEHC Position: Q2 2026 in Review

EntryPoint Capital sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 5,208 shares — an estimated $371K sold.

EntryPoint Capital first reported a position in GEHC in Q4 2023 and held it in 7 quarters. The position peaked at $591K in Q1 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • EntryPoint Capital reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • EntryPoint Capital sold 5,208 GE HealthCare shares in Q2 2026, an estimated $371K.
  • EntryPoint Capital first reported a position in GE HealthCare in Q4 2023 and held it in 7 quarters.
  • EntryPoint Capital's GE HealthCare position peaked at $591K in Q1 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.